Feasibility of Using Hydrogel Spacers for Borderline-Resectable and Locally Advanced Pancreatic Tumors.

Gastroenterology

Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institutions, Baltimore, Maryland. Electronic address:

Published: October 2019

This article has an accompanying continuing medical education activity, also eligible for MOC credit, on page e14 (https://www.gastrojournal.org/cme/home). Learning Objective: Upon completion of this CME activity, successful learners will be able to describe the pharmacokinetics of hydrogel, identify appropriate candidates for hydrogel injection among patients with pancreatic cancer, and describe key techniques to successfully inject hydrogel as well as the histopathologic findings associated with hydrogel.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263852PMC
http://dx.doi.org/10.1053/j.gastro.2019.07.012DOI Listing

Publication Analysis

Top Keywords

feasibility hydrogel
4
hydrogel spacers
4
spacers borderline-resectable
4
borderline-resectable locally
4
locally advanced
4
advanced pancreatic
4
pancreatic tumors
4
tumors article
4
article accompanying
4
accompanying continuing
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!